Current
376.30 €
+1.08% today
Start price
292.50 €
Target price
329.44 €
+33.5% to target
End price
246.85 €
Performance (%)
-15.61%
Return to target
+33.5%
Confidence
50%
Time horizon
2025-05-03
Performance since start
How it ranks
- #200 Rank 200 of 207 by performance
- 199 ratings for this instrument performed better
- 49 other running ratings for this instrument
Summary
This prediction ended on 04.05.25 with a price of €246.85. The price of Amgen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.61%. Dividends of €8.50 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this prediction
Timeline & discussion
Reasoning and updates for this rating
The discussion is visible to sharewise members.
2 comments are waiting for you.